Vir Biotechnology Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 16.33 M | $98.47 M | 2.27% | 11.75% |
| SB INVESTMENT ADVISERS (UK) LTD | 02/18/2026 | 13.12 M | $79.10 M | -21.38% | 9.44% |
| ARCH VENTURE MANAGEMENT, LLC | 02/17/2026 | 12.92 M | $77.89 M | 0.00% | 9.30% |
| VANGUARD GROUP INC | 01/29/2026 | 12.55 M | $75.67 M | -1.96% | 9.03% |
| GSK PLC | 02/12/2026 | 8.55 M | $51.56 M | 100.00% | 6.15% |
| STATE STREET CORP | 02/13/2026 | 6.23 M | $37.56 M | 18.86% | 4.48% |
| FMR LLC | 02/17/2026 | 3.16 M | $19.05 M | -13.16% | 2.27% |
| MORGAN STANLEY | 02/13/2026 | 2.68 M | $16.16 M | -0.37% | 1.93% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 2.54 M | $15.29 M | -14.86% | 1.83% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 2.38 M | $14.36 M | 0.00% | 1.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.33 M | $14.04 M | 3.65% | 1.68% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.57 M | $9.46 M | 3.10% | 1.13% |
| ABRDN PLC | 01/16/2026 | 1.39 M | $8.39 M | -8.89% | 1.00% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 1.37 M | $8.25 M | 100.00% | 0.99% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 1.33 M | $7.99 M | 45.30% | 0.95% |
| CANDRIAM S.C.A. | 04/30/2026 | 1.03 M | $6.22 M | 100.00% | 0.74% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.00 M | $6.05 M | -28.21% | 0.72% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 930.91 K | $5.61 M | 132.16% | 0.67% |
| 02/17/2026 | 930.32 K | $5.61 M | 100.00% | 0.67% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 904.48 K | $5.45 M | -20.86% | 0.65% |
| NORTHERN TRUST CORP | 02/17/2026 | 848.47 K | $5.12 M | -6.47% | 0.61% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 731.31 K | $4.41 M | 276.44% | 0.53% |
| BOXER CAPITAL MANAGEMENT, LLC | 02/17/2026 | 625.00 K | $3.77 M | 100.00% | 0.45% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 614.46 K | $3.71 M | -47.35% | 0.44% |
| NORDEA INVESTMENT MANAGEMENT AB | 01/08/2026 | 609.73 K | $3.55 M | -14.67% | 0.44% |
| CLARIUS GROUP, LLC | 01/14/2026 | 608.20 K | $3.67 M | -1.79% | 0.44% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 598.67 K | $3.50 M | 31.20% | 0.43% |
| HRT FINANCIAL LP | 02/12/2026 | 591.65 K | $3.57 M | 234.67% | 0.43% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 589.56 K | $3.56 M | -9.20% | 0.42% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 577.70 K | $3.48 M | 14.62% | 0.42% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 575.71 K | $3.47 M | -2.98% | 0.41% |
| NUVEEN, LLC | 02/12/2026 | 565.54 K | $3.41 M | 175.23% | 0.41% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 545.56 K | $3.29 M | -2.06% | 0.39% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 542.54 K | $3.27 M | 0.00% | 0.39% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 531.43 K | $3.20 M | -4.24% | 0.38% |
| ALTA PARTNERS MANAGEMENT COMPANY, L.P. | 01/13/2026 | 509.92 K | $3.07 M | 0.00% | 0.37% |
| CITADEL ADVISORS LLC | 02/17/2026 | 489.23 K | $2.95 M | -38.77% | 0.35% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 478.34 K | $2.88 M | 0.00% | 0.34% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 450.60 K | $2.72 M | -1.12% | 0.32% |
| JPMORGAN CHASE & CO | 02/11/2026 | 418.60 K | $2.52 M | -6.88% | 0.30% |
| UBS GROUP AG | 01/29/2026 | 417.97 K | $2.52 M | 94.62% | 0.30% |
| INVESCO LTD. | 02/19/2026 | 405.70 K | $2.45 M | -2.93% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 390.06 K | $2.35 M | 40.46% | 0.28% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 371.29 K | $2.24 M | 3.02% | 0.27% |
| BARCLAYS PLC | 02/13/2026 | 365.83 K | $2.21 M | -10.86% | 0.26% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 327.39 K | $1.97 M | -36.63% | 0.24% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 326.17 K | $1.97 M | -11.19% | 0.23% |
| CITIGROUP INC | 02/13/2026 | 311.29 K | $1.88 M | -3.78% | 0.22% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 295.39 K | $1.78 M | -0.21% | 0.21% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 281.54 K | $1.70 M | 11.58% | 0.20% |
Vir Biotechnology Inc institutional Ownership - FAQ's
During the previous two years, 293 institutional investors and hedge funds held shares of Vir Biotechnology Inc. The most heavily invested institutionals were:
Pictet Asset Management Holding SA: 1.48 M
Candriam S.C.A.: 1.14 M
Nuveen, LLC: 1.02 M
UBS Group AG: 744,142
Bank of New York Mellon Corp: 584,047
PRINCIPAL FINANCIAL GROUP INC: 547,753
83.17% of Vir Biotechnology Inc stock is owned by institutional investors.
Institutional investors have bought a total of 136.11 M shares in the last 24 months. This purchase volume represents approximately $1.33 B in transactions.